AI Biotech Iambic Gets $150M in IPO Cash for ‘Molecular Superintelligence’ Drug R&D
Iambic Therapeutics, an AI-enabled biotech firm, will apply the IPO proceeds towards medical improvement of its pipeline of internally found ...
Tag: 150M
Aidoc Rakes In $150M for Its Clinical Decision Support AI
Israeli clinical AI startup Aidoc closed a $150 million funding round led by General Catalyst and Square Peg on Wednesday, ...
Acadia Pharma Sells Voucher for Speedier FDA Drug Review for $150M
Acadia Pharmaceuticals committed a lot of money for rights to Daybue, which in the biotech’s hands became the first FDA-approved ...
GSK, Flagship Pioneering Commit $150M to Start R&D Pact for Novel Drugs and Vaccines
GSK already has a strong presence in respiratory disease and immunology, two of its core therapeutic areas. The pharmaceutical giant ...
Imperative Care closes potential $150M Series E and more digital health fundings
Medical technology company Imperative Care announced it initially closed an oversubscribed Series E financing round led by Ally Bridge Group. ...
Discover the latest in health and fitness with Your Health 247. Get expert advice, workout routines, healthy recipes, and mental wellness tips to lead a healthier, happier life. Stay informed and empowered with us!